1. Home
  2. CNH vs BBIO Comparison

CNH vs BBIO Comparison

Compare CNH & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNH Industrial N.V.

CNH

CNH Industrial N.V.

HOLD

Current Price

$10.60

Market Cap

12.7B

Sector

Industrials

ML Signal

HOLD

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$66.80

Market Cap

12.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNH
BBIO
Founded
1842
2015
Country
United Kingdom
United States
Employees
34197
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.7B
12.7B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
CNH
BBIO
Price
$10.60
$66.80
Analyst Decision
Buy
Strong Buy
Analyst Count
11
25
Target Price
$13.00
$86.33
AVG Volume (30 Days)
10.3M
2.6M
Earning Date
04-30-2026
05-12-2026
Dividend Yield
0.99%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$502,076,000.00
Revenue This Year
N/A
$89.45
Revenue Next Year
$8.21
$73.78
P/E Ratio
$31.00
N/A
Revenue Growth
N/A
126.26
52 Week Low
$9.00
$39.65
52 Week High
$13.87
$84.94

Technical Indicators

Market Signals
Indicator
CNH
BBIO
Relative Strength Index (RSI) 49.39 47.06
Support Level $9.85 $62.39
Resistance Level $11.13 $69.78
Average True Range (ATR) 0.40 2.47
MACD -0.00 0.26
Stochastic Oscillator 53.47 63.77

Price Performance

Historical Comparison
CNH
BBIO

About CNH CNH Industrial N.V.

CNH Industrial is the world's second largest manufacturer of agricultural machinery (82% of industrial net sales) as well as a major player in construction equipment (18% of industrial net sales). Its Case and New Holland brands have served farmers for generations. Geographically, agricultural sales are 40% in North America, 32% in Europe, the Middle East, and Africa, 18% in South America, and 10% in Asia-Pacific. CNH's products are available through a robust independent dealer network, which includes over 2,600 dealer and distribution locations and reach into 164 countries. The construction business leverages over 400 dealers. The company's captive finance arm provides retail financing to its customers and wholesale financing to dealers to maintain inventory, thereby supporting sales.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: